Feed Preview

Photobiomodulation & Neuromodulation

Photobiomodulation & Neuromodulation diagram by Natoli et al, PLOS One
Natoli et al, PLOS One

This feed focuses on different types of light therapies and methods, including optogenetics and low-level laser applications.

Top 20 most recent papers
Annual Review of Neuroscience

Synaptic Plasticity Forms and Functions

Annual Review of NeuroscienceFebruary 21, 2020
Jeffrey C Magee, Christine Grienberger
24
Cell

General Anesthesia Decouples Cortical Pyramidal Neurons

CellFebruary 22, 2020
Mototaka Suzuki, Matthew E Larkum
274
1
Nature Reviews. Genetics

Optogenetic control of single mRNA spatiotemporal dynamics

Nature Reviews. GeneticsFebruary 21, 2020
Linda Koch
92
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V

Cell-cargo Mediated ZrN Nanoparticle for the Synergetic Phototherapy on Both of Mice and Rabbits

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.VFebruary 23, 2020
Siqi WangChongshen Guo
Nanoscale Research Letters

High-Performance Deep Ultraviolet Photodetector Based on NiO/β-Ga2 O3 Heterojunction

Nanoscale Research LettersFebruary 24, 2020
Menghan JiaShu Ping Lau
ACS Applied Materials & Interfaces

Gold Nanobipyramid-Based Nanotheranostics for Dual-Modality Imaging Guided Phototherapy

ACS Applied Materials & InterfacesFebruary 22, 2020
Chunxiao LiZhiming Li
Ultrasound in Medicine & Biology

Focused Ultrasound Platform for Investigating Therapeutic Neuromodulation Across the Human Hippocampus

Ultrasound in Medicine & BiologyFebruary 24, 2020
Spencer T BrinkerEllen J Bubrick
Annals of Oncology : Official Journal of the European Society for Medical Oncology

Photosensitizer-based multimodal nanocomposites as a theranostic agent for near infrared (NIR)-guided cancer-targeting synergistic chemo-phototherapy

Annals of Oncology : Official Journal of the European Society for Medical OncologyFebruary 22, 2020
T PonrajS Kannan

See more papers from this feed

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Age-related Dementia

Age-related dementia (Alzheimer's disease) results from the destructive impact of the pulse on cerebral vasculature. Evidence is reviewed that the neuropathology of the dementia is caused by the breakdown of small cerebral vessels (silent microbleeds), that the microbleeds result from pulse-induced damage to the cerebral vessels, and that pulse becomes increasingly destructive with age, because of the age-related stiffening of the aorta and great arteries, which causes an increase in the intensity of the pressure pulse. Discover the latest research on age-related dementia here.

© 2020 Meta ULC. All rights reserved
/feed-previews/photobiomodulation-neuromodulation/60cb612a-fc8e-4df3-b03f-67ed5d403749